Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 14Neoplasms 8Breast Neoplasms 5Hypogonadism 3Eunuchism 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Obesity 2Metabolic Syndrome 2Fatigue 2Dyspareunia 2Arthralgia 2Vaginitis 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcopenia 1Osteoporosis 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Diseases 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hot Flashes 1Diabetes Mellitus 1

Interventions

Testosterone 2Laser Therapy 2Coconut Oil 2Water 1Vitamin E 1Transcranial Direct Current Stimulation 1Testosterone Propionate 1Sodium Chloride 1Replens 1Physical Therapy Modalities 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dyspareunia × Testosterone × Clear all
NCT01697345 2014-01-24

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy

Creighton University

Phase EARLY_PHASE1 Completed
12 enrolled 22 charts
Breast

Breast Neoplasms, Dyspareunia

NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

University of Vermont

Phase 1/2 Suspended
30 enrolled
Breast

Breast Neoplasms, Dyspareunia, Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡